OBJECTIVE: To investigate the effect of a dietary intervention to reduce body weight on red cell aggregation (RCA), factor VII activity, plasminogen activator inhibitor (PAI) activity, tissue plasminogen activator (t-PA) antigen, ®brino-gen, whole blood and plasma viscosity, haematocrit and lipids. DESIGN: Open single stranded study of dietary intervention for weight loss in a volunteer sample. SUBJECTS: Forty-®ve subjects whose BMI exceeded 26 kgam 2 were recruited and received dietetic advice designed to reduce body weight by 0.5 kg per week. MEASUREMENTS: Body weight and waist and hip circumferences, dietary intake by seven day weighed inventory, RCA, factor VII activity, PAI activity, t-PA antigen, ®brinogen, whole blood and plasma viscosity, haematocrit and lipids. RESULTS: After 12 weeks of dietary intervention there were reductions in body weight and BMI by 5.9 (s.d. 3.3) kg and 1.9 (s.d. 1.0) kgam 2 respectively in males, and 4.1 (s.d. 2.9) kg and 1.6 (s.d. 1.1) kgam 2 in females (P`0.0001). Factor VII activity (P 0.0043), RCA (P 0.01) and t-PA antigen (P 0.016) were reduced in females after weight reduction but no differences were found in PAI activity, whole blood, plasma viscosity or haematocrit. The changes in factor VII activity and RCA were appropriate for the changes in BMI on the basis of the relationships of the risk factors with BMI in a cross sectional survey of a representative Scottish population. Plasma total cholesterol was reduced (P 0.016) but HDL cholesterol and triglycerides remained unchanged. There were signi®cant associations between the reductions in factor VII activity and BMI (r 0.395, P 0.013) and between the reductions in RCA and waist to hip ratio (r 0.350, P 0.04). No relationship was seen between changes in serum cholesterol and changes in factor VII activity or RCA. CONCLUSIONS: Modest weight loss, of 5% body weight, with conventional dietary intervention reduces two established risk factors for ischaemic heart disease (factor VII activity and RCA) which are generally elevated in those with increased body weight.
Introduction
Overweight is an important risk factor for ischaemic heart disease (IHD) mortality. 1 Elevations in blood pressure, blood lipids and insulin encourage atheroma, and contribute to an increased tendency towards thrombosis in the overweight. Overweight individuals have elevated plasma coagulation factor VII activity, 2, 3 ®brinogen concentrations 3, 4 and impaired ®bri-nolysis with an increased plasminogen activator inhibitor (PAI) activity. 5 Elevations of all three indices are related to increased risk of IHD. 2, 4 Raised rheological indices of blood¯ow, haematocrit, whole blood and plasma viscosity and red cell aggregation (RCA) have been shown to be related to IHD, 6 stroke and peripheral disease. 7 In the overweight and in non insulin dependent diabetes (NIDDM) RCA is elevated. 8, 9 Abdominal fat distribution, indicated by an increased waist to hip ratio (WHR), also negatively in¯uences both coagulation and ®brinolysis. 10 Clinical studies have shown altered coagulation and ®brinolytic measurements in the overweight, 10±12 and that the indices of coagulation and ®brinolysis can be improved with weight loss. 13±15 These studies used very low calorie diet (VLCD) regimens, where effects from acute, severe energy restriction are likely to confound effects of weight loss per se. 16 The present study used currently recommended dietary advice 17 and a moderate daily energy restriction to investigate the effects of dietary intervention and weight loss on coagulation, ®brinolytic and rheological variables.
Patients and methods
Fifty-eight overweight subjects (49 female and 9 male) were recruited both from a local obesity clinic and from local advertisements. Recruitment was car-ried out throughout a whole year to minimise any seasonal in¯uences. Twenty one subjects who received the same dietary intervention were also participating in a double blind placebo controlled trial of the lipase inhibitor Orlistat (Roche Products Ltd, Welwyn Garden City), a weight reducing agent. 18 Those with any signi®cant cardiovascular abnormalities or diabetes 19 were excluded. All subjects were free of any medication known to in¯uence haemostatic measures, such as oral contraceptives or diuretics. 7 All subjects described at least one period of slimming in the preceding two year period before commencing the study, though no one had reduced their weight by greater than 3 kg within the three month period prior to recruitment. Subjects attended as outpatients on ®ve occasions over the 12 week study period. Body weight was measured using standard methods and calibrated scales. Body fat distribution was evaluated using WHR, according to the method of Lean et al. 20 The sample size was suf®cient to detect a clinically important difference at 80% power and a 5% level of signi®cance for factor VII activity and RCA.
Results were compared with existing data from a representative sample of the West of Scotland population recruited for the Third north Glasgow MONICA survey. 21 This represents a random sample from the parent population of the study sample. Analysis of RCA and factor VII activity for the MONICA study were made using the same methodology as employed for study subjects, as were anthropometric measurements. For males and females, subsets of the MONICA population were selected using very similar selection criteria as used for the present study. These included being in good health, not following a special diet, never ever having been given a doctor diagnosis of stroke, angina or myocardial infarction and having no ECG abnormality. A total of 521 males and 562 females ful®lled these criteria. Values were obtained for both RCA and body mass index (BMI) from 368 males and for 361 females, and 431 males and 409 females had results for both factor VII activity and BMI.
A regression line was ®tted for BMI for both RCA and factor VII activity against BMI, and the 95% con®dence intervals for the mean values were calculated by sex group.
Dietary intervention used an individual dietary prescription based on the Scho®eld equation 22 to predict resting energy expenditure. No subjects reported regular physical activity, and hence an activity factor of basal metabolic rate 6 1.3 was used to estimate daily energy requirements. 17 A 2510 kJ (600 kcal) daily energy de®cit was applied and the resulting prescription was adjusted to the nearest 418 kJ (100 kcal). The dietary composition was designed to provide greater than 50% energy from carbohydrate, less than 35% energy from fat, and under 20% from protein. Energy from fat was divided into 10% energy from each of monounsaturated, polyunsaturated and saturated fatty acids. Advice was given to restrict alcohol to six units per week. Dietary intake was monitored by the completion of four day weighed inventories during study week 1 and week 12. Household measures were used when food weights were not recorded. Two consecutive weekend days and two weekdays were used for recording. Four day food intake data were adjusted to the equivalent of a seven day 23 to reduce bias towards the weekend food consumption. Dietary analysis was carried out using the Compeat 4.0 dietary analysis system, (Lifesystems, London) based on current food tables. 24 Venesection was performed before (week 0) and after (week 12) dietary intervention. To minimise any diurnal variations, blood was sampled between the hours of 9±11 am following a ®ve minute supine rest. Alcohol consumption was forbidden in the preceding 24 h period. Blood for rheological measures was drawn from the anticubital vein with a minimum of stasis. Blood for viscosity and lipid measurements was anticoagulated with ethylenediaminetetracetic acid and blood for thrombotic measurements was treated with 0.109 m sodium citrate. Aliquots of plasma were stored at 770 C for later analysis. Whole blood and plasma viscosity were measured at high shear rates (over 300 s
71
) at 37 C in a Harkness capillary viscometer. 25 Haematocrit was measured with a Hawksley micro-centrifuge. Red cell aggregation was assessed photometrically in the Myrenne cone-plate aggregometer (Myrenne GmbH, Roetgan, Germany). 26 The aggregometer consisted of a transparent perspex cone and plastic plate. The latter was ®xed in position and shearing of the sample was achieved by rotation of the cone. Infra red light transmitted through the sample was measured by a photometer which produced photovoltages processed in the microprocessor unit within the machine. Twenty ®ve microlitres of whole blood at 25 C were dropped on the cone and the sample spun at 600 s 71 for 10 s to disperse aggregates, before being stopped abruptly. The extent of aggregation in stasis was determined as the change in light transmission over 5 s, was integrated via the microprocessor unit and recorded digitally as the aggregation index. The mean of two readings was taken. The ®ndings were represented without correcting for haematocrit, as we have shown no haematocrit effect within the normal range. Fibrinogen was measured using the automated Clauss thrombin-clotting assay 27 and a Coag-A Mate X2 coagulometer (Organon Teknika, Cambridge, UK). Calibration was carried out with both a plasma pool and manufacturers standards and the intra and inter assay coef®cients of variation were 5.0 and 3.2% respectively. Factor VII activity was measured using a one stage clotting assay, which used human factor VII de®cient plasma (Sigma Chemical Co., Poole, Dorset, UK) and rabbit thromboplastin. Results were recorded as a percentage of a reference plasma pool.
The total plasma concentrations of t-PA antigen were determined by an enzyme-linked immunosorbent assay kit (Tintelize t-PA, Biopool, Sweden). The intra and inter assay precision was`9.0% and`9.0% respectively. PAI activity was measured using a chromogenic microtiter assay (COAtestPAI, Chromogenix) with an intra assay precision of`8.0% and an inter-assay variation`8.0%. Results were expressed as PAI activity as a percentage of a normal plasma pool. Triglycerides and total cholesterol were measured on an automated analysis system (Boehringer Mannheim, Lewes, Sussex). High density lipoprotein cholesterol (HDL) was measured using b-quanti®ca-tion and ultracentrifugation with the removal of low density lipoprotein cholesterol (LDL) by precipitation with heparin and manganous chloride.
Data for the differences in biological measurements before and after dietary intervention were approximately normally distributed, as determined from a distribution plot, and were thus analysed using a paired Student's t-test. The differences between the two dietary data measurements showed a skewed distribution and were thus analysed using a paired Wilcoxon test. Pearson's correlation analysis was carried out to investigate any relationships between changes in body weight or BMI, and changes in the haematological, ®brinolytic and plasma lipid measurements.
Ethical approval for the study was obtained from the Glasgow Royal In®rmary Joint Ethics Committee and signed informed consent was obtained from all study participants.
Results
Thirteen female subjects failed to complete the study, and were excluded from all analyses. The characteristics of the 45 subjects (36 female), who completed the study are shown in Table 1 Weight reduction and thrombotic risks CR Hankey et al differences were found between dietary records for macronutrient or percentage energies from particular nutrients for either sex. The subjects' haemostatic and ®brinolytic measurements are shown in Table 3 . Red cell aggregation was signi®cantly reduced after intervention in females (P 0.01) but not in males (P 0.73). The MONICA relationship between RCA and BMI for all the men and women in the study subsample are shown in Figure 1 . The 95% con®dence intervals represent the anticipated limits for the mean RCA at individual ®xed BMIs. For the study population the baseline and post intervention values for mean RCA against mean BMI are shown as arrows. After weight loss, the mean RCA for females, but not males fell (see also Table 3 ).
Mean factor VII activity was the only coagulation measure signi®cantly reduced in females (P 0.0043) although the result was not signi®cant in the nine males only (P 0.27). The MONICA relationships for factor VII activity against BMI for the subset from the area in which the study sample was recruited are shown in Figure 1 . The 95% con®dence intervals represent the anticipated limits for the mean factor VII activity at individual ®xed BMIs. For the study population the baseline and post intervention values for factor VII activity are shown as arrows. There was a reductions in t-PA antigen concentrations after diet- 114 (10) 115 (22) 107 (10) 108 (22) ary intervention in females (P 0.015) but not in males (P 0.09). Plasma cholesterol was reduced in females (P 0.03) and HDL cholesterol and triglyceride remained unchanged. Use of Pearson's correlation analysis revealed a signi®cant relationship between the reductions in BMI and in factor VII activity (r 0.395, P 0.01) ( Figure  2 ) and between the reductions in both RCA and in WHR (r 0.340, P 0.04) (Figure 3) . No relationship was found between changes in haemostatic and rheological measures and serum lipid concentrations, or between changes in RCA, t-PA antigen or WHR.
Discussion
This study has demonstrated improvements in two measures of IHD risk: RCA and factor VII activity after moderate weight loss. The mean values for the men sit exactly on the MONICA data. The women have lower factor VII activity and RCA in relation to their BMI compared to the MONICA data. The subset was selected using the inclusion criteria for the current study applied to its' parent population, a random, representative West of Scotland sample.
The MONICA comparison has provided information about the relationships between factor VII activity and BMI and RCA and BMI. Figure 1 shows useful information about how these pairs of variables are related from a large random population sample. However, the 95% con®dence intervals only provide a guide as to what is anticipated about the relationships between mean RCA and mean factor VII activity and mean BMI because the con®dence intervals are valid for the individual, rather than the mean BMI. The baseline values for study subjects represented by the base of the arrows, are closer to the regression line than the week 12 values (the line tip) Figure 1 . This probably re¯ects the acute effect of weight loss.
The weight loss of 5.9 kg in males and 4.1 kg in females after 12 weeks in this study is comparable with that achieved by the majority of other workers using a conventional dietary approach. 28 No signi®-cant changes between reported nutrient intakes at baseline and week 12 were found. This may be partly explained by under reporting, a recognised feature in the reported dietary intakes completed by those who are overweight. It may also account for no change in reported dietary intakes despite the weight loss achieved. 24 The increased RCA in the overweight (Figure 1 ) as compared with a subset of the Third north Glasgow MONICA survey population is in agreement with previous studies in overweight NIDDM, 9 adults and children. 11, 29, 30 The overall 13% reduction achieved in this study is comparable with the results of other studies in healthy overweight subjects. 11 The association between reduced abdominal fat distribution and RCA could suggest a mechanism related to insulin resistance. However other workers have found no clear evidence of a relationship between changes in haemorheological and WHR values.
11
Elevated whole blood and plasma viscosities have been shown in overweight subjects when compared with those within the range of 20±25 kgam 2 BMI, 29 and also in overweight subjects with an elevated WHR compared with those with an acceptable ratio (`0.8 for women,`1.0 for men). 31 Raised plasma and whole blood viscosities have been reported in studies of the overweight. 8, 11, 12 study 11 was 5% higher than in our study, although the values measured in this study were comparable with a representative West of Scotland population. 31 An 11% weight loss in adolescents with BMI greater than 30 kgam 2 reduced plasma viscosity signi®cantly, 8 and in adults a 17% weight loss from a BMI of 42.6 signi®cantly reduced plasma viscosity. 32 Increased WHR in¯uenced blood rheology, particularly whole blood viscosity, and haematocrit, 31 but not plasma viscosity. Blood viscosity showed signi®cant reductions with a 17% weight loss when differences were corrected at 45% haematocrit, and measured at a low shear rate. 32 The amount of weight loss and the starting BMI appear to be key factors in achieving signi®cant reductions in plasma and whole blood viscosity. 28, 32 It seems likely that our subjects, slimmer at baseline than those in other studies 28, 32 did not lose suf®cient weight to alter either plasma or blood viscosity.
An elevated haematocrit is associated with increased blood viscosity and has been shown as a signi®cant risk factor for non fatal myocardial infarction and coronary disease. 33 Our subjects' haematocrit were not elevated when compared with the non obese population, and were unchanged with weight loss. These ®ndings are in agreement with some 8, 32 but at variance 11, 28 with other studies. Plasma ®brinogen concentration is another important determinant of plasma viscosity. 34 The signi®cant decrease in RCA was not, however, due to any decrease in ®brinogen. Our results follow those of other studies which suggest that the in¯uence of both dietary intervention and weight loss to reduce plasma ®brinogen are small. 13±15,29,32 Existing studies which have reported both the effects of weight loss and dietary change on ®brinogen levels have been equivocal. 35 Fehily et al 36 suggested that the in¯uence of dietary intake on plasma ®brinogen was in the region of 5%, with cereal ®bre intake showing an inverse relationship with plasma ®brinogen.
Factor VII activity was lower in the overweight in this study (Figure 1 ) as compared to a subset of the Third north Glasgow MONICA survey population. The in¯uence of factor VII activity as an indicator of increased coronary risk has been demonstrated by epidemiological studies 2±4 and linked with increased body weight and dietary fat intake. 37 The overall 10% reduction in factor VII activity achieved in our study is close to the results of other studies. 13, 37 Similar differences in factor VII activity were demonstrated between groups of those at high and low heart disease risk within two large epidemiological surveys. 2, 4 In contrast, Baron et al 38 achieved similar weight loss using a 1200 kcal diet to that in our study, though factor VII activity remained unchanged.
The in¯uence of dietary fat intake on factor VII activity was considered by Miller et al. 39 They found an association between total dietary fat intake and factor VII activity, and a signi®cant decrease was seen in factor VII activity with reductions in dietary fat intake (31% energy from fat) without weight loss. A similar dietary intervention (32% energy from fat) with two different fat compositions, a low or high polyunsaturated to saturated fat ratio also signi®cantly lowered factor VII activity. 40 Our study did not ®nd a relationship between dietary fat intake and factor VII activity at baseline, or between changes in these variables after intervention.
The two components of the ®brinolytic system PAI and t-PA antigen measured in our study are related to overweight and to increased IHD risk. 5, 10, 41 An elevated PAI activity has been associated with obesity and with raised WHR. 5, 30 Signi®cant reductions in PAI-1 and t-PA antigen have been shown after weight loss 5, 10, 42 which are double that observed in this present study. The reason for a reduction in t-PA antigen but not PAI activity in female subjects in our study is unclear.
The reduction in serum cholesterol following weight loss is in agreement with the majority of the literature. 43 However, the stability of HDL cholesterol and triglyceride found in this study following weight loss are in contrast with the majority of publications, 44 and could re¯ect the result of insuf®cient weight loss.
Conclusions
In summary, these data suggest that dietary intervention and moderate weight loss signi®cantly improves three coagulation and rheological indices linked with increased IHD risk, (factor VII activity, RCA and t-PA antigen), with less pronounced effects on PAI activity.
